These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 9519902

  • 1. The ankyrin-binding domain of CD44s is involved in regulating hyaluronic acid-mediated functions and prostate tumor cell transformation.
    Zhu D, Bourguignon LY.
    Cell Motil Cytoskeleton; 1998; 39(3):209-22. PubMed ID: 9519902
    [Abstract] [Full Text] [Related]

  • 2. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF, Zhu D, Bourguignon LY.
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of CD44 in pl85(neu)-transfected NIH3T3 cells promotes an up-regulation of hyaluronic acid-mediated membrane-cytoskeleton interaction and cell adhesion.
    Zhu D, Bourguignon L.
    Oncogene; 1996 Jun 06; 12(11):2309-14. PubMed ID: 8649770
    [Abstract] [Full Text] [Related]

  • 4. Rho-kinase (ROK) promotes CD44v(3,8-10)-ankyrin interaction and tumor cell migration in metastatic breast cancer cells.
    Bourguignon LY, Zhu H, Shao L, Zhu D, Chen YW.
    Cell Motil Cytoskeleton; 1999 Jun 06; 43(4):269-87. PubMed ID: 10423269
    [Abstract] [Full Text] [Related]

  • 5. Interaction between CD44 and the repeat domain of ankyrin promotes hyaluronic acid-mediated ovarian tumor cell migration.
    Zhu D, Bourguignon LY.
    J Cell Physiol; 2000 May 06; 183(2):182-95. PubMed ID: 10737894
    [Abstract] [Full Text] [Related]

  • 6. Ankyrin-binding domain of CD44(GP85) is required for the expression of hyaluronic acid-mediated adhesion function.
    Lokeshwar VB, Fregien N, Bourguignon LY.
    J Cell Biol; 1994 Aug 06; 126(4):1099-109. PubMed ID: 7519619
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. CD44v10 interaction with Rho-kinase (ROK) activates inositol 1,4,5-triphosphate (IP3) receptor-mediated Ca2+ signaling during hyaluronan (HA)-induced endothelial cell migration.
    Singleton PA, Bourguignon LY.
    Cell Motil Cytoskeleton; 2002 Dec 06; 53(4):293-316. PubMed ID: 12378540
    [Abstract] [Full Text] [Related]

  • 15. Coexpression of CD44 variant (v10/ex14) and CD44S in human mammary epithelial cells promotes tumorigenesis.
    Iida N, Bourguignon LY.
    J Cell Physiol; 1997 May 06; 171(2):152-60. PubMed ID: 9130462
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Binding of CD44 to hyaluronic acid can be induced by multiple signals and requires the CD44 cytoplasmic domain.
    Liu D, Zhang D, Mori H, Sy MS.
    Cell Immunol; 1996 Nov 25; 174(1):73-83. PubMed ID: 8929456
    [Abstract] [Full Text] [Related]

  • 18. Hyaluronan binding by CD44 is regulated by a phosphorylation-independent mechanism.
    Uff CR, Neame SJ, Isacke CM.
    Eur J Immunol; 1995 Jul 25; 25(7):1883-7. PubMed ID: 7542594
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Site-specific de-N-glycosylation of CD44 can activate hyaluronan binding, and CD44 activation states show distinct threshold densities for hyaluronan binding.
    English NM, Lesley JF, Hyman R.
    Cancer Res; 1998 Aug 15; 58(16):3736-42. PubMed ID: 9721887
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.